Carmen Álvarez‐Navascués

Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis

Álvaro Díaz‐González, Ida Schregel, Lorena Carballo‐Folgoso, Carmen Álvarez‐Navascués et autres

Background & Aims: The goal of treatment for autoimmune hepatitis is to achieve a complete biochemical response, defined as normalization of transaminases and immunoglobulin G (IgG) levels. Recent data suggest that IgG normalization does not significantly affect survival. We evaluated the impact …

es, de, nl (code pays fourni par la source)

THU-350-YI Impact of non-classical phenotypes of primary biliary cholangitis on treatment response and long-term prognosis. Results from the ColHai registry

Pinelopi Arvaniti, Helena Hernandéz Evole, Magdalena Salcedo, Ignasi Olivas et autres

SAT-358 Dynamics and prognostic implications of splanchnic volumetry in patients withportosinusoidal vascular liver disorder

José Ferrusquía‐Acosta, Damián Gil-Bello, Katharina Lampichler, Marta Vidal et autres

OS-086 Evaluation of the response criteria following second-line treatment with bezafibrate in patients with primary biliary cholangitis

Helena Hernández-Évole, Ignasi Olivas, Nerea Quintans, Cristina Montón et autres

GS-004 Development of portal hypertension after non-cirrhotic non-tumoral recent portal vein thrombosis (RPVT). A long-term follow-up study

Berta Bartrolí Alabau, Aurélie Plessier, F. Martinón Sánchez, Audrey Payancé et autres

Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis

Pinelopi Arvaniti, Sergio Rodríguez‐Tajes, Marlene Padilla, Ignasi Olivas et autres

es, ar, ca, be, nl, de, pl, tr, it, ch, us, pt, gr (code pays fourni par la source)

The role of immigration in chronic hepatitis B and C in Asturias: origin and characteristics of the patients. An observational, cross-sectional study.

Ángela Suárez-Noya, Carmen Álvarez‐Navascués, Mercedes Rodríguez, Valle Cadahía-Rodrigo et autres

OBJECTIVE: to understand the burden of immigration in chronic hepatitis B (CHB) and C (CHC) in our setting and the characteristics of immigrants with each infection. MATERIALS AND METHODS: an observational, descriptive, and cross-sectional study was performed that included all patients attended …

es (code pays fourni par la source)

Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis

Pinelopi Arvaniti, Sergio Rodríguez Tajes, Sara Lorente-Pérez, Isabel Conde et autres

Arvaniti, Pinelopi; Rodríguez-Tajes, Sergio; Padilla, Marlene; Olivas, Ignasi; Mauro, Ezequiel; El Maimouni, Cautar; Lytvyak, Ellina; Verhelst, Xavier; Engel, Bastian; Taubert, Richard; Lorente-Pérez, Sara; Conde, Isabel; Riveiro-Barciela, Mar; Ruiz-Cobo, Juan-Carlos; Álvarez-Navascués, Carmen; Salcedo, Magdalena; Gómez, Judith; Janik, Maciej K; Mateos, Beatriz; Efe, Cumali; …

Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study

Valeria Pérez‐Campuzano, Pierre‐Emmanuel Rautou, Thomas Marjot, Michael Praktiknjo et autres

Background & Aims: Patients with vascular liver diseases (VLD) are at higher risk of both severe courses of COVID-19 disease and thromboembolic events. The impact of SARS-CoV-2 vaccination in patients with VLD has not been described and represents the aim of our …

es, fr, gb, de, it, at, be (code pays fourni par la source)

Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry

Mar Riveiro‐Barciela, Ana Barreira‐Díaz, Paula Esteban García, Carmen Álvarez‐Navascués et autres

BACKGROUND AND AIMS: Small series suggest that rituximab could be effective as treatment for autoimmune hepatitis (AIH), although data are scarce. We aimed to evaluate the efficacy and safety of rituximab in different cohorts of patients with AIH. METHODS: Multicentre retrospective analysis …

es, de (code pays fourni par la source)

Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors

Rosa Martín‐Mateos, Laura Martínez‐Arenas, Ângela Carvalho‐Gomes, Laia Aceituno et autres

es (code pays fourni par la source)

Predictive models for hepatocellular carcinoma development after sustained virological response in advanced hepatitis C

Miguel Fraile López, Carmen Álvarez‐Navascués, Maria Luisa González-Diéguez, Valle Cadahía et autres

es (code pays fourni par la source)